uy
Journal Home
Search for

Volume 56, Issue 1, Pages 95-101 (July 2010)


View previous. 16 of 38 View next.

The Impact of Nonidentical ABO Deceased Donor Kidney Transplant on Kidney Utilization

Liise K. Kayler, MD, MS1Corresponding Author Informationemail address, Dorry L. Segev, MD, PhD23

Received 23 September 2009; accepted 5 January 2010. published online 29 March 2010.

Background

Blood type AB kidney transplant candidates have the shortest waiting times, yet the current allocation system allows allocation of type A donor kidneys to type AB recipients.

Study Design

United Network for Organ Sharing/Organ Procurement and Transplantation Network data between 1995 and 2004, retrospective observational study.

Setting & Participants

189,773 candidates listed for kidney-only transplant; 93,604 kidneys transplanted, 15,580 kidneys discarded.

Predictor

Blood type and demographic/clinical variables.

Outcomes & Measurements

The extent of disparities in waiting times and concurrent differences in recovery, discard, live donor, and deceased donor transplant rates.

Results

Blood type O, A, B, and AB candidates constituted 48%, 34%, 14%, and 4% of the list, respectively. Live donor transplant rates were lowest for type AB candidates (13.4% vs 15.5%, 16.8%, and 15.2%; P < 0.001). On multivariate analysis, type AB candidates had a 1.5-fold greater chance of receiving deceased donor kidney transplants than blood group A candidates (95% CI, 1.45-1.55). Recovery rates of type AB kidneys were similar to those for other blood types, whereas discard rates of type AB kidneys were significantly higher (adjusted OR [aOR], 1.71; 95% CI, 1.56-1.89) for both expanded criteria (aOR, 1.78; 95% CI, 1.52-2.09) and standard criteria donors (aOR, 1.67; 95% CI, 1.48-1.89).

Limitations

Observational data. Potential confounding from unmeasured covariates.

Conclusion

Allocation of type A kidneys to type AB recipients not only increases disparities in waiting times between these 2 groups; but concurrent with the shorter waiting times for type AB candidates, there is suboptimal use of type AB deceased donor and living donor kidneys.

1 Department of Surgery, Shands Hospital at the University of Florida, Gainesville, FL

2 Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD

3 Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD

Corresponding Author InformationAddress correspondence to Liise K. Kayler, MD, MS, 1600 SW Archer Rd, PO Box 100118, Rm 6142, Gainesville, FL 32610

 Originally published online as doi:10.1053/j.ajkd.2010.01.014 on March 29, 2010.

PII: S0272-6386(10)00479-8

doi:10.1053/j.ajkd.2010.01.014


View previous. 16 of 38 View next.